Through the detection of cell apoptosis markers Bcl‐2 and Bax in the treated or control groups and a data comparison between the different groups, the synergistic effects between metformin and pemetrexed on NSCLC or sensitization effect of metformin to chemotherapy were verified again. The gene discussed is BCL2; the disease is non-small cell lung carcinoma.